Adult-Onset Immunodeficiency in Thailand and Taiwan
- 23 August 2012
- journal article
- research article
- Published by Massachusetts Medical Society in The New England Journal of Medicine
- Vol. 367 (8), 725-734
- https://doi.org/10.1056/nejmoa1111160
Abstract
Autoantibodies against interferon-γ are associated with severe disseminated opportunistic infection, but their importance and prevalence are unknown. We enrolled 203 persons from sites in Thailand and Taiwan in five groups: 52 patients with disseminated, rapidly or slowly growing, nontuberculous mycobacterial infection (group 1); 45 patients with another opportunistic infection, with or without nontuberculous mycobacterial infection (group 2); 9 patients with disseminated tuberculosis (group 3); 49 patients with pulmonary tuberculosis (group 4); and 48 healthy controls (group 5). Clinical histories were recorded, and blood specimens were obtained. Patients in groups 1 and 2 had CD4+ T-lymphocyte counts that were similar to those in patients in groups 4 and 5, and they were not infected with the human immunodeficiency virus (HIV). Washed cells obtained from patients in groups 1 and 2 had intact cytokine production and a response to cytokine stimulation. In contrast, plasma obtained from these patients inhibited the activity of interferon-γ in normal cells. High-titer anti–interferon-γ autoantibodies were detected in 81% of patients in group 1, 96% of patients in group 2, 11% of patients in group 3, 2% of patients in group 4, and 2% of controls (group 5). Forty other anticytokine autoantibodies were assayed. One patient with cryptococcal meningitis had autoantibodies only against granulocyte–macrophage colony-stimulating factor. No other anticytokine autoantibodies or genetic defects correlated with infections. There was no familial clustering. Neutralizing anti–interferon-γ autoantibodies were detected in 88% of Asian adults with multiple opportunistic infections and were associated with an adult-onset immunodeficiency akin to that of advanced HIV infection. (Funded by the National Institute of Allergy and Infectious Diseases and the National Institute of Dental and Craniofacial Research; ClinicalTrials.gov number, NCT00814827.)Keywords
This publication has 28 references indexed in Scilit:
- Anti-CD20 (rituximab) therapy for anti–IFN-γ autoantibody–associated nontuberculous mycobacterial infectionBlood, 2012
- Acquired predisposition to mycobacterial disease due to autoantibodies to IFN-γJCI Insight, 2005
- Infections Associated With Tumor Necrosis Factor-α AntagonistsMedicine, 2005
- Human genetics of intracellular infectious diseases: molecular and cellular immunity against mycobacteria and salmonellaeThe Lancet Infectious Diseases, 2004
- HIV infection/acquired immunodeficiency syndrome at Siriraj Hospital, 2002: time for secondary prevention.2004
- Naturally occurring anti–IFN-γ autoantibody and severe infections with Mycobacterium cheloneae and Burkholderia cocovenenansBlood, 2004
- Autoantibodies to Interferon‐γ in a Patient with Selective Susceptibility to Mycobacterial Infection and Organ‐Specific AutoimmunityClinical Infectious Diseases, 2004
- Infections with rapidly growing mycobacteria: report of 20 casesInternational Journal of Infectious Diseases, 2003
- Tuberculosis-associated Severe CD4+ T-Lymphocytopenia in HIV-Seronegative Patients from DakarJournal of Infection, 2000
- Disseminated Infection Due to Rapidly Growing Mycobacteria in Immunocompetent Hosts Presenting with Chronic Lymphadenopathy: A Previously Unrecognized Clinical EntityClinical Infectious Diseases, 2000